STEVENSON, Md., March 19, 2018 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Ubiquiti Networks, Inc. (Nasdaq:UBNT) (“Ubiquiti” or the “Company”) securities during the period between May 9, 2013 and February 20, 2018, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until April 23, 2018 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Ubiquiti securities during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that the number of the Company’s purported user community was drastically overstated and that Ubiquiti had exaggerated its publicly reported accounts receivable.
According to the complaint, following the Company’s February 20, 2018 filing of Form 8-K with the Securities and Exchange Commission (“SEC”) stating that on February 13, 2018, the SEC issued subpoenas to Ubiquiti and certain of the Company’s officers requesting documents and information relating to a range of topics, including metrics relating to the Ubiquiti Community, accounting practices, financial information, auditors, international trade practices, and relationships with distributors and various other third parties, the value of Ubiquiti shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in Ubiquiti securities purchased on or after May 9, 2013 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please contact Brower Piven either by email at [email protected] or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven
Brower Piven, A Professional Corporation
1925 Old Valley Road
Stevenson, Maryland 21153
Telephone: 410-415-6616
[email protected]


Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
Apple Restores Telegram to App Store After Content Policy Violation
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Jetstar to Charge for Overhead Cabin Bags From February
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip 



